29 September 2023 - Pricing and subsidy methods and processes need to be developed to address the challenges that arise when new treatments, such as precision medicine and advanced therapy drugs, are to be made available to patients.
The Dental and Pharmaceutical Benefits Agency, TLV, today presents a report on the continued work.